Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background: Blood immunoreactive biomarkers, such as C-reactive protein (CRP), and metabolic abnormalities have been associated with schizophrenia. Studies comprehensively and bidirectionally probing possible causal links between such blood constituents and liability to schizophrenia are lacking. Methods: To disentangle putative causal links between CRP blood levels and schizophrenia in both directions, we conducted multiple univariable Mendelian-randomization (MR) analyses, ranging from fixed-effect to inverse variance-weighted (IVW), weighted-median, MR Egger and generalized summary-data-based Mendelian-randomization (GSMR) models. To prioritize metabolic risk factors for schizophrenia, a novel multivariable approach was applied: multivariable Mendelian-randomization–Bayesian model averaging (MR-BMA). Results: All forward univariable MR analyses consistently showed that CRP has a protective effect on schizophrenia, whereas reverse MR analyses consistently suggested absent causal effects of schizophrenia liability on CRP blood levels. Using MR-BMA, as the top protective factors for schizophrenia we prioritized leucine and as the prime risk-factor triglycerides in medium very-low-density lipoprotein (VLDL). The five best-performing MR-BMA models provided one additional risk factor: triglycerides in large VLDL; and two additional protective factors: citrate and lactate. Conclusions: Our results add to a growing body of literature hinting at metabolic changes—in particular of triglycerides—independently of medication status in schizophrenia. We also highlight the absent effects of genetic liability to schizophrenia on CRP levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Third, we show that the previously reported protective effect of CRP on schizophrenia (Hartwig et al., 2017; Lin et al., 2019) could be explained by IL-6, an upstream inducer of CRP production.”
From Associations of Immunological Proteins/Traits with Schizophrenia, Major Depression and Bipolar Disorder: A Bi-Directional Two-Sample Mendelian Randomization Study (2021) · cites this paper as Lin et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Inoshita, M., Numata, S., Tajima, A., Kinoshita, M., Umehara, H., Nakataki, M., Ikeda, M., Maruyama, S., Yamamori, H., Kanazawa, T., et al. (2018) · Scientific Reports · doi:10.1038/srep46947 · Cited by 10
RetractedBowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Bowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404 · cited 1×
“MR is a powerful approach to disentangle putative causal effects of a risk factor (or exposure) on an outcome using genetic variants as instrumental variables.(19) Common MR approaches comprise inverse variance-weighted (IVW), weighted-median(20) and MR Egger,(21) and include sensitivity analyses testing whether certa…”
BackgroundAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
EPIC- InterAct Consortium, Burgess, S., Scott, R. A., Timpson, N. J., Davey Smith, G., & Thompson, S. G. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0011-z · Cited by 1,803
Bias due to participant overlap in two‐sample Mendelian randomization
Burgess, S., Davies, N. M., & Thompson, S. G. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21998 · Cited by 1,624
Burgess, S., & Thompson, S. G. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu283 · Cited by 1,605
GERAD1 Consortium, Pardiñas, A. F., CRESTAR Consortium, Holmans, P., Pocklington, A. J., Escott-Price, V., Ripke, S., Carrera, N., Legge, S. E., Bishop, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0059-2 · Cited by 1,552
Causal associations between risk factors and common diseases inferred from GWAS summary data
Zhu, Z., Zheng, Z., Zhang, F., Wu, Y., Trzaskowski, M., Maier, R., Robinson, M. R., McGrath, J. J., Visscher, P. M., Wray, N. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02317-2 · Cited by 951
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926 · cited 2×
“Moreover, elevated CRP levels in childhood/adolescence increase the odds of developing psychosis in adulthood.(6) However, in contrast to these findings, recently published Mendelian-randomization (MR) studies show that CRP may play a protective rather than a risk-increasing role in schizophrenia—a discrepancy that ha…”
BackgroundResultKettunen, J., Demirkan, A., Würtz, P., Draisma, H. H. M., Haller, T., Rawal, R., Vaarhorst, A., Kangas, A. J., Lyytikäinen, L.-P., Pirinen, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11122 · Cited by 738
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.167 · Cited by 659
Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
Puzianowska-Kuźnicka, M., Owczarz, M., Wieczorowska-Tobis, K., Nadrowski, P., Chudek, J., Slusarczyk, P., Skalska, A., Jonas, M., Franek, E., & Mossakowska, M. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0076-x · Cited by 445
Prins, B. P., Abbasi, A., Wong, A., Vaez, A., Nolte, I., Franceschini, N., Stuart, P. E., Guterriez Achury, J., Mistry, V., Bradfield, J. P., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001976 · Cited by 199 · cited 1×
“Protective effects of CRP on schizophrenia were previously revealed by multiple MR studies.(7,9) apparently contradicting clinical observations.”
BackgroundInterpretation and Potential Biases of Mendelian Randomization Estimates With Time-Varying Exposures
Labrecque, J. A., & Swanson, S. A. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwy204 · Cited by 139
L-Lactate protects neurons against excitotoxicity: implication of an ATP-mediated signaling cascade
Jourdain, P., Allaman, I., Rothenfusser, K., Fiumelli, H., Marquet, P., & Magistretti, P. J. (2016) · Scientific Reports · doi:10.1038/srep21250 · Cited by 116 · cited 1×
“In addition, lactate plays a neuroprotective role against excitotoxicity, oxidative stress and damage from trauma.(50,51) Possibly, lactate may in the same manner protect against vulnerability to SCZ.”
Background
Research works printed but not linked: 34
- Miller, 2014, C-reactive protein levels in schizophrenia: a review and meta-analysis, Clin Schizophr Relat Psychoses, 7, 223, 10.3371/CSRP.MICU.020813 · DOI · Paper page
- Gonzalez-Blanco, 2018, Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia, Psychiatry Res, 269, 688, 10.1016/j.psychres.2018.08.042 · DOI
- Fond, 2018, C-Reactive protein as a peripheral biomarker in schizophrenia: an updated systematic review, Front Psychiatry, 9, 392, 10.3389/fpsyt.2018.00392 · DOI
- Hartwig, 2017, Inflammatory biomarkers and risk of schizophrenia: a 2-sample Mendelian randomization study, JAMA Psychiatry, 74, 1226, 10.1001/jamapsychiatry.2017.3191 · DOI · Paper page
- Cordes, 2017, Prevalence of metabolic syndrome in female and male patients at risk of psychosis, Schizophr Res, 181, 38, 10.1016/j.schres.2016.09.012 · DOI
- Ryan, 2003, Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia, Am J Psychiatry, 160, 284, 10.1176/appi.ajp.160.2.284 · DOI · Paper page
- Chen, 2016, Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits, Psychol Med, 46, 3219, 10.1017/S0033291716001902 · DOI
- Spelman, 2007, Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia, Diabet Med, 24, 481, 10.1111/j.1464-5491.2007.02092.x · DOI · Paper page
- Thakore, 2002, Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia, Int J Obes Relat Metab Disord, 26, 137, 10.1038/sj.ijo.0801840 · DOI · Paper page
- Guest, 2010, Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patients, Mol Psychiatry, 15, 118, 10.1038/mp.2009.81 · DOI
- van Beveren, 2014, Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia, Transl Psychiatry, 4, e430, 10.1038/tp.2014.52 · DOI
- Suhre, 2012, Genetic variation in metabolic phenotypes: study designs and applications, Nat Rev Genet, 13, 759, 10.1038/nrg3314 · DOI · Paper page
- Hebebrand, 2018, The role of genetic variation of human metabolism for BMI, mental traits and mental disorders, Mol Metab, 12, 1, 10.1016/j.molmet.2018.03.015 · DOI
- Zuber, 2018, Selecting causal risk factors from high-throughput experiments using multivariable Mendelian randomization, bioRxiv, 396333.
- Ligthart, 2018, Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders, Am J Hum Genet, 103, 691, 10.1016/j.ajhg.2018.09.009 · DOI · Paper page
- Bowden, 2016, Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I-2 statistic, Int J Epidemiol, 45, 1961
- 1979, Cook RD. Influential observations in linear-regression, J Am Stat Assoc, 74, 169, 10.1080/01621459.1979.10481634 · DOI · Paper page
- Hans, 2007, Shotgun Stochastic search for ‘Large p’ regression, J Am Stat Assoc, 102, 507, 10.1198/016214507000000121 · DOI · Paper page
- Yavorska, 2017, Mendelian randomization: an R package for performing Mendelian randomization analyses using summarized data, Int J Epidemiol, 46, 1734, 10.1093/ije/dyx034 · DOI · Paper page
- Orsolini, 2018, Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review, Curr Neuropharmacol, 16, 583, 10.2174/1570159X16666180119144538 · DOI · Paper page
- Saetre, 2007, Inflammation-related genes up-regulated in schizophrenia brains, BMC Psychiatry, 7, 46, 10.1186/1471-244X-7-46 · DOI · Paper page
- Garcia-Rizo, 2013, Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features (vol 198, pg 212, 2012), Psychiatry Res, 210, 1329., 10.1016/j.psychres.2013.08.041 · doi:10.1016/j.psychres.2013.08.041
- Jacomb, 2018, C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls, Front Immunol, 9, 1, 10.3389/fimmu.2018.02230 · DOI · Paper page
- Khandaker, 2012, Childhood infection and adult schizophrenia: a meta-analysis of population-based studies, Schizophr Res, 139, 161, 10.1016/j.schres.2012.05.023 · DOI · Paper page
- Benros, 2016, Influence of polygenic risk scores on the association between infections and schizophrenia, Biol Psychiatry, 80, 609, 10.1016/j.biopsych.2016.04.008 · DOI
- He, 2012, Schizophrenia shows a unique metabolomics signature in plasma, Transl Psychiatry, 2, e149, 10.1038/tp.2012.76 · DOI · Paper page
- Solberg, 2016, Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study, BMC Psychiatry, 16, 299., 10.1186/s12888-016-1006-3 · DOI · Paper page
- Zeynep, 2018, The relationship between serum lipid levels and lifetime suicide attempts in patients with schizophrenia, Med Sci, 7, 724
- Bjerkenstedt, 1987, Plasma and muscle amino-acids in relation to cerebrospinal-fluid monoamine metabolites in schizophrenic-patients and healthy controls, Int J Neurosci, 32, 707
- De Luca, 2008, Psychiatry Investig, 5, 203, 10.4306/pi.2008.5.4.203 · DOI
- Duncan, 2018, Genetic correlation profile of schizophrenia mirrors epidemiological results and suggests link between polygenic and rare variant (22q11.2) cases of schizophrenia, Schizophr Bull, 44, 1350, 10.1093/schbul/sbx174 · DOI
- Xuan, 2011, Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action, J Proteome Res, 10, 5433, 10.1021/pr2006796 · DOI · Paper page
- Matsui, 2017, Astrocytic glycogen-derived lactate fuels the brain during exhaustive exercise to maintain endurance capacity, Proc Natl Acad Sci USA, 114, 6358, 10.1073/pnas.1702739114 · DOI · Paper page
- Berthet, 2009, Neuroprotective role of lactate after cerebral ischemia, J Cereb Blood Flow Metab, 29, 1780, 10.1038/jcbfm.2009.97 · DOI · Paper page
Cited by
Perry, B. I., Upthegrove, R., Kappelmann, N., Jones, P. B., Burgess, S., & Khandaker, G. M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.009 · Cited by 187
Gao, Z., Li, B., Guo, X., Bai, W., & Kou, C. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04760-6 · Cited by 22
Metadata
- Authors
- Lin, B. D., Alkema, A., Peters, T., Zinkstok, J., Libuda, L., Hebebrand, J., Antel, J., Hinney, A., Cahn, W., Adan, R., & Luykx, J. J.
- Affiliations
- Department of Psychiatry, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands
- Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Duisburg-Essen, University Hospital Essen, Essen, Germany
- Department of Translational Neuroscience, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-08-31
- Volume
- 48
- Issue
- 5
- Pages
- 1505-1514
- ISSN
- 0300-5771
- 1464-3685
- Cited by
- 58
- References
- 18
- Language
- en
- Funders
- German Ministry for Education and Research
- National Genome Research Net-Plus (01GS0820)
- German Research Foundation
- European Community's Seventh Framework Programme (245009, 262055)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.